BioCorRx (BICX) EBITDA Margin (2011 - 2026)
BioCorRx's (BICX) quarterly EBITDA Margin came in at 444.39% in Q1 2026, up 24811.0% year-on-year from N/an in Q1 2025, and down 136.12% quarter-over-quarter from 188.21% in Q4 2025.
BioCorRx (BICX) EBITDA Margin (2011 - 2026) Analysis & Trends
BioCorRx has disclosed EBITDA Margin across 16 years of filings, most recently posting 444.39% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 444.39%, up 24811.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 421.41% (up 322211.0% YoY), and the FY2025 annual result was 604.17%, up 6580860.0% from the prior year.
- EBITDA Margin came in at 444.39% for Q1 2026 at BioCorRx, down from 188.21% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 188.21% in Q4 2025 to a low of 33694.26% in Q2 2024.
- The 5-year median for EBITDA Margin is 2596.17% (2023), against an average of 6691.39%.
- Across the five-year window, EBITDA Margin tumbled 2890445 bps in 2024 and soared 3290331 bps in 2025, its largest moves.
- BioCorRx's EBITDA Margin stood at 1422.86% in 2022, then sank by 203 bps to 4310.34% in 2023, then slumped by 682 bps to 33694.26% in 2024, then surged by 99 bps to 188.21% in 2025, then plunged by 136 bps to 444.39% in 2026.
- The last three EBITDA Margin figures came in at 444.39% (Q1 2026), 188.21% (Q4 2025), and 461.44% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 83.85 Bn | 86.23 Bn | 16.26 Bn | -2.96% |
| 2 | Tenet Healthcare | 14.98 Bn | 14.15 Bn | 4.41 Bn | 24.14% |
| 3 | Davita | 13.99 Bn | 14.84 Bn | 1.07 Bn | 14.11% |
| 4 | Encompass Health | 9.72 Bn | 10.34 Bn | 1.34 Bn | 3.76% |
| 5 | Ensign | 8.90 Bn | 8.31 Bn | 293.37 Mn | 8.99% |
| 6 | Universal Health Services | 8.59 Bn | 8.55 Bn | 3.21 Bn | 11.19% |
| 7 | Fresenius Medical Care AG | 7.67 Bn | 5.29 Bn | -4.26 Bn | 4,926.74% |
| 8 | Chemed | 5.97 Bn | 5.96 Bn | 215.76 Mn | 15.04% |
| 9 | Pacs | 5.74 Bn | 5.50 Bn | 345.96 Mn | 8.45% |
| 10 | BioCorRx | - | - | 189,355.00 | -444.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -444.39% |
| Dec 31, 2025 | -188.21% |
| Sep 30, 2025 | -461.44% |
| Jun 30, 2025 | -790.96% |
| Mar 31, 2025 | -692.50% |
| Jun 30, 2024 | -33,694.26% |
| Mar 31, 2024 | -26,582.13% |
| Dec 31, 2023 | -4,310.34% |
| Sep 30, 2023 | -9,417.93% |
| Jun 30, 2023 | -4,789.82% |
| Mar 31, 2023 | -2,596.17% |
| Dec 31, 2022 | -1,422.86% |
| Sep 30, 2022 | -1,082.75% |
| Jun 30, 2022 | -8,447.62% |
| Mar 31, 2022 | -5,449.39% |
| Dec 31, 2021 | -9,742.67% |
| Sep 30, 2021 | -18,464.17% |
| Jun 30, 2021 | -6,072.28% |
| Mar 31, 2021 | -15,543.59% |
| Dec 31, 2020 | -7,918.14% |